| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Integrative Physiology |
From the Division of Cardiovascular Medicine (M.P., S.M., F.Y., A.D., A.J.M., S.S.S.), The Gill Heart Institute, University of Kentucky, Lexington; Carolina Cardiovascular Biology Center (M.R., C.E., C.V., S.S.S.), University of North Carolina, Chapel Hill; Department of Pharmacology (K.L.), University of Virginia, Charlottesville; Department of Molecular Biology (J.C.), The Scripps Research Institute, San Diego, Calif; and Department of Veterans Affairs Medical Center (S.S.S.), Lexington, Ky.
Correspondence to Susan S. Smyth, MD, PhD, The Gill Heart Institute, 326 Charles T. Wethington Building, 900 S Limestone St, Lexington, KY 40536. E-mail susansmyth{at}uky.edu
Phenotypic modulation of vascular smooth muscle cells (SMCs) is essential for the development of intimal hyperplasia. Lysophosphatidic acid (LPA) is a serum component that can promote phenotypic modulation of cultured SMCs, but an endogenous role for this bioactive lipid as a regulator of SMC function in vivo has not been established. Ligation injury of the carotid artery in mice increased levels in the vessel of both autotaxin, the lysophospholipase D enzyme responsible for generation of extracellular LPA, and 2 LPA responsive G protein–coupled receptors 1 (LPA1) and 2 (LPA2). LPA1–/–2–/– mice were partially protected from the development of injury-induced neointimal hyperplasia, whereas LPA1–/– mice developed larger neointimal lesions after injury. Growth in serum, LPA-induced extracellular signal-regulated protein kinase activation, and migration to LPA and serum were all attenuated in SMCs isolated from LPA1–/–2–/– mice. In contrast, LPA1–/– SMCs exhibited enhanced migration resulting from an upregulation of LPA3. However, despite their involvement in intimal hyperplasia, neither LPA1 nor LPA2 was required for dedifferentiation of SMCs following vascular injury or dedifferentiation of isolated SMCs in response to LPA or serum in vitro. Similarly, neither LPA1 nor LPA2 was required for LPA to elicit a transient increase in blood pressure following intravenous administration of LPA to mice. These results identify a role for LPA1 and LPA2 in regulating SMC migratory responses in the context of vascular injury but suggest that additional LPA receptor subtypes are required for other LPA-mediated effects in the vasculature.
Key Words: arterial injury lipids lysophosphatidic acid vascular remodeling vascular smooth muscle cells
This article has been cited by other articles:
![]() |
D. Meredith, M. Panchatcharam, S. Miriyala, Y.-S. Tsai, A. J. Morris, N. Maeda, G. A. Stouffer, and S. S. Smyth Dominant-Negative Loss of PPAR{gamma} Function Enhances Smooth Muscle Cell Proliferation, Migration, and Vascular Remodeling Arterioscler Thromb Vasc Biol, April 1, 2009; 29(4): 465 - 471. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Skoura and T. Hla Lysophospholipid receptors in vertebrate development, physiology, and pathology J. Lipid Res., April 1, 2009; 50(Supplement): S293 - S298. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |